Clinical Trial

Brain Health in Transgender Adults

Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this study is to test whether and how a person's brain changes in the first few months after starting gender affirming hormone therapy (GAHT). The investigators want to know if GAHT changes: 1) cerebral blood flow (CBF), 2) brain structure, connectivity, and cognitive task performance, and 3) neurocognitive function (memory, attention, executive function, processing speed). 36 male at birth and 36 female at birth participants will conduct baseline studies prior to GAHT, with a second identical set of study visits 4-6 months after GAHT begins.
Trial Details
NCT Number NCT07624747
Lead Sponsor University of Wisconsin, Madison
Conditions Gender Dysphoria
Enrollment 72 participants
Start Date 2025-10-14
Primary Completion 2028-04 (estimated)
Study Completion 2028-04 (estimated)
Updated on ClinicalTrials.gov 2026-06-03